Date: 19 January 2017
Reactivation of hepatitis B has been reported rarely following treatment with pomalidomide plus dexamethasone in patients previously infected with the hepatitis B virus (HBV). HBV status should be established before treatment with pomalidomide is initiated. A Direct Healthcare Professional Communication (DHPC) has been issued by Celgene Sdn. Bhd. in agreement with NPRA to highlight this information. Please refer to this DHPC for further information.